Cargando…

Oncogenic KRAS promotes malignant brain tumors in zebrafish

BACKGROUND: Zebrafish have been used as a vertebrate model to study human cancers such as melanoma, rhabdomyosarcoma, liver cancer, and leukemia as well as for high-throughput screening of small molecules of therapeutic value. However, they are just emerging as a model for human brain tumors, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Bensheng, Chen, Wenbiao, Orr, Brent A, Spitsbergen, Jan M, Jia, Sujuan, Eden, Christopher J, Henson, Hannah E, Taylor, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320811/ https://www.ncbi.nlm.nih.gov/pubmed/25644510 http://dx.doi.org/10.1186/s12943-015-0288-2

Ejemplares similares

Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish
por: Ju, Bensheng, et al.
Publicado: (2009)

Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras(V12) expression in transgenic zebrafish
por: Nguyen, Anh Tuan, et al.
Publicado: (2016)

Functional and genetic analysis of choroid plexus development in zebrafish
por: Henson, Hannah E., et al.
Publicado: (2014)

A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish
por: Nguyen, Anh Tuan, et al.
Publicado: (2011)

Males develop faster and more severe hepatocellular carcinoma than females in kras(V12) transgenic zebrafish
por: Li, Yan, et al.
Publicado: (2017)

Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway
por: Ju, B, et al.
Publicado: (2014)

An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening
por: Nguyen, Anh Tuan, et al.
Publicado: (2012)

Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish
por: Yan, Chuan, et al.
Publicado: (2015)

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Orthotopic models of pediatric brain tumors in zebrafish
por: Eden, Christopher J., et al.
Publicado: (2014)

Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish
por: Yang, Qiqi, et al.
Publicado: (2018)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor
por: Flasch, Diane A., et al.
Publicado: (2022)

Immune modulatory effects of oncogenic KRAS in cancer
por: Hamarsheh, Shaima’a, et al.
Publicado: (2020)

Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)

Conquering oncogenic KRAS and its bypass mechanisms
por: Hou, Pingping, et al.
Publicado: (2022)

Mutant KRAS promotes malignant pleural effusion formation
por: Αgalioti, Theodora, et al.
Publicado: (2017)

Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
por: Boutin, Adam T., et al.
Publicado: (2017)

G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription
por: Cogoi, Susanna, et al.
Publicado: (2006)

ahctf1 and kras mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma
por: Morgan, Kimberly J, et al.
Publicado: (2023)

Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides
por: Wang, Dali, et al.
Publicado: (2022)

Zebrafish model of KRAS-initiated pancreatic cancer
por: Park, Joon Tae, et al.
Publicado: (2018)

Myc-Induced Liver Tumors in Transgenic Zebrafish Can Regress in tp53 Null Mutation
por: Sun, Lili, et al.
Publicado: (2015)

Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
por: Sabnis, Amit J, et al.
Publicado: (2009)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
por: Liu, Xinquan, et al.
Publicado: (2019)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

A sart1 Zebrafish Mutant Results in Developmental Defects in the Central Nervous System
por: Henson, Hannah E., et al.
Publicado: (2020)

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway
por: Conti, Annalisa, et al.
Publicado: (2015)

MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells
por: Phelps, Grace B., et al.
Publicado: (2022)

Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine–dependent interface: a model for KRAS oligomerization
por: Lee, Ki-Young, et al.
Publicado: (2021)

Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
por: Kong, Bo, et al.
Publicado: (2013)

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
por: Ogishima, Juri, et al.
Publicado: (2018)

Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine
por: Wang, Kai-Bo, et al.
Publicado: (2022)

Zebrafish model of KRAS-initiated pancreatic endocrine tumor
por: Oh, Sekyung, et al.
Publicado: (2019)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_788qok7r07f8cm10mpa097hvkl